Clinical trials
Phase 1 Leukemia, Myeloid, Acute trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
| Active, not recruiting | 3 |
| Completed | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| University Hospital, Antwerp | 2 |
| Boehringer Ingelheim | 1 |
| Byondis B.V. | 1 |
| Celyad Oncology SA | 1 |
| Eli Lilly and Company | 1 |
| Hemavant Sciences GmbH | 1 |
| Janssen Research & Development, LLC | 1 |
| Menarini Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 15 |
| Myelodysplastic Syndromes | 6 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Recurrence | 3 |
| Leukemia | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasm, Residual | 2 |
| Astrocytoma | 1 |
| Cholangiocarcinoma | 1 |
| Glioblastoma | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.